166 related articles for article (PubMed ID: 12760419)
21. Botulinum neurotoxin C1 cleaves both syntaxin and SNAP-25 in intact and permeabilized chromaffin cells: correlation with its blockade of catecholamine release.
Foran P; Lawrence GW; Shone CC; Foster KA; Dolly JO
Biochemistry; 1996 Feb; 35(8):2630-6. PubMed ID: 8611567
[TBL] [Abstract][Full Text] [Related]
22. Long-distance retrograde effects of botulinum neurotoxin A.
Antonucci F; Rossi C; Gianfranceschi L; Rossetto O; Caleo M
J Neurosci; 2008 Apr; 28(14):3689-96. PubMed ID: 18385327
[TBL] [Abstract][Full Text] [Related]
23. Differential roles of developmentally distinct SNAP-25 isoforms in the neurotransmitter release process.
Puffer EB; Lomneth RB; Sarkar HK; Singh BR
Biochemistry; 2001 Aug; 40(31):9374-8. PubMed ID: 11478906
[TBL] [Abstract][Full Text] [Related]
24. Botulinum neurotoxin E-insensitive mutants of SNAP-25 fail to bind VAMP but support exocytosis.
Washbourne P; Bortoletto N; Graham ME; Wilson MC; Burgoyne RD; Montecucco C
J Neurochem; 1999 Dec; 73(6):2424-33. PubMed ID: 10582602
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of neurotransmitter release by botulinum neurotoxins and tetanus toxin at Aplysia synapses: role of the constituent chains.
Poulain B; Mochida S; Wadsworth JD; Weller U; Habermann E; Dolly JO; Tauc L
J Physiol (Paris); 1990; 84(4):247-61. PubMed ID: 1981913
[TBL] [Abstract][Full Text] [Related]
26. Persistence of botulinum neurotoxin action in cultured spinal cord cells.
Keller JE; Neale EA; Oyler G; Adler M
FEBS Lett; 1999 Jul; 456(1):137-42. PubMed ID: 10452545
[TBL] [Abstract][Full Text] [Related]
27. SNAP-25 is required for a late postdocking step in Ca2+-dependent exocytosis.
Banerjee A; Kowalchyk JA; DasGupta BR; Martin TF
J Biol Chem; 1996 Aug; 271(34):20227-30. PubMed ID: 8702751
[TBL] [Abstract][Full Text] [Related]
28. Longer-acting and highly potent chimaeric inhibitors of excessive exocytosis created with domains from botulinum neurotoxin A and B.
Wang J; Zurawski TH; Bodeker MO; Meng J; Boddul S; Aoki KR; Dolly JO
Biochem J; 2012 May; 444(1):59-67. PubMed ID: 22360156
[TBL] [Abstract][Full Text] [Related]
29. Enhancement of the endopeptidase activity of purified botulinum neurotoxins A and E by an isolated component of the native neurotoxin associated proteins.
Sharma SK; Singh BR
Biochemistry; 2004 Apr; 43(16):4791-8. PubMed ID: 15096048
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of neurotransmitter release by clostridial neurotoxins correlates with specific proteolysis of synaptosomal proteins.
Blasi J; Binz T; Yamasaki S; Link E; Niemann H; Jahn R
J Physiol Paris; 1994; 88(4):235-41. PubMed ID: 7874084
[TBL] [Abstract][Full Text] [Related]
31. PKC modulation of transmitter release by SNAP-25 at sensory-to-motor synapses in aplysia.
Houeland G; Nakhost A; Sossin WS; Castellucci VF
J Neurophysiol; 2007 Jan; 97(1):134-43. PubMed ID: 16971689
[TBL] [Abstract][Full Text] [Related]
32. Botulinum neurotoxin types A and E require the SNARE motif in SNAP-25 for proteolysis.
Washbourne P; Pellizzari R; Baldini G; Wilson MC; Montecucco C
FEBS Lett; 1997 Nov; 418(1-2):1-5. PubMed ID: 9414082
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of neurotransmitter release by synthetic proline-rich peptides shows that the N-terminal domain of vesicle-associated membrane protein/synaptobrevin is critical for neuro-exocytosis.
Cornille F; Deloye F; Fournié-Zaluski MC; Roques BP; Poulain B
J Biol Chem; 1995 Jul; 270(28):16826-32. PubMed ID: 7622497
[TBL] [Abstract][Full Text] [Related]
34. Rescue of exocytosis in botulinum toxin A-poisoned chromaffin cells by expression of cleavage-resistant SNAP-25. Identification of the minimal essential C-terminal residues.
O'Sullivan GA; Mohammed N; Foran PG; Lawrence GW; Oliver Dolly J
J Biol Chem; 1999 Dec; 274(52):36897-904. PubMed ID: 10601242
[TBL] [Abstract][Full Text] [Related]
35. Differential contribution of syntaxin 1 and SNAP-25 to secretion in noradrenergic and adrenergic chromaffin cells.
Baltazar G; Tomé A; Carvalho AP; Duarte EP
Eur J Cell Biol; 2000 Dec; 79(12):883-91. PubMed ID: 11152280
[TBL] [Abstract][Full Text] [Related]
36. Plasma membrane targeting of SNAP-25 increases its local concentration and is necessary for SNARE complex formation and regulated exocytosis.
Koticha DK; McCarthy EE; Baldini G
J Cell Sci; 2002 Aug; 115(Pt 16):3341-51. PubMed ID: 12140265
[TBL] [Abstract][Full Text] [Related]
37. A molecular basis underlying differences in the toxicity of botulinum serotypes A and E.
Bajohrs M; Rickman C; Binz T; Davletov B
EMBO Rep; 2004 Nov; 5(11):1090-5. PubMed ID: 15486565
[TBL] [Abstract][Full Text] [Related]
38. Dynamics of motor nerve terminal remodeling unveiled using SNARE-cleaving botulinum toxins: the extent and duration are dictated by the sites of SNAP-25 truncation.
Meunier FA; Lisk G; Sesardic D; Dolly JO
Mol Cell Neurosci; 2003 Apr; 22(4):454-66. PubMed ID: 12727443
[TBL] [Abstract][Full Text] [Related]
39. Selective cleavage of SNAREs in sensory neurons unveils protein complexes mediating peptide exocytosis triggered by different stimuli.
Meng J; Dolly JO; Wang J
Mol Neurobiol; 2014 Oct; 50(2):574-88. PubMed ID: 24604356
[TBL] [Abstract][Full Text] [Related]
40. Gβγ and the C terminus of SNAP-25 are necessary for long-term depression of transmitter release.
Zhang XL; Upreti C; Stanton PK
PLoS One; 2011; 6(5):e20500. PubMed ID: 21633701
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
